Live feed08:00:57·1658dSECFilingvia QuantisnowBridgeBio Pharma, Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Obligation, Other Events, Financial Statements and ExhibitsByQuantisnow·Wall Street's wire, on your screen.BBIO· BridgeBio Pharma Inc.Health CareOriginal source
